Yes, many people stay on blood thinners indefinitely, even for life, if their risk for dangerous clots (like from atrial fibrillation or recurring DVT) is high, while others only need them temporarily (months) for specific events like surgery or a first-time clot, with the duration depending entirely on the underlying medical condition and doctor's assessment. Lifelong use is common for conditions that inherently increase clot risk, but it's always weighed against the increased bleeding risk, with doctors managing dosage and monitoring closely.
Recurrence risk: If you have a history of DVT or other clotting disorders, your doctor might recommend longer-term or even lifelong blood thinner use to prevent future events.
Stopping blood thinners can increase your risk for blood clots, due to the underlying risk factor(s) for which your blood thinner was originally prescribed. Many times, these bleeding and clotting risks can be complicated for you to understand, and difficult for your healthcare providers to manage.
Although very rare, hematoma due to oral anticoagulants can also be observed in the breast. Breast hematomas can be managed with supportive treatment without any intervention.
Patients with Afib, a common type of arrhythmia, or irregular heart rhythm, face a fivefold risk of stroke and are therefore often prescribed blood-thinning medications (anticoagulants) to slow blood clotting.
A personal survey of patients with atrial fibrillation (AF), one of the most important causes of irregular heartbeats, has found that the majority of triggers for the condition are easily modifiable lifestyle choices, including alcohol, caffeine, exercise and lack of sleep.
If you have a heart problem like atrial fibrillation, you might need to take apixaban long term or even for the rest of your life. Do not stop taking apixaban without talking to your doctor. If you stop taking apixaban, your risk of blood clots will return to what it was before.
Anticoagulants are extremely effective in preventing life-threatening conditions like stroke, pulmonary embolism and heart attack.
The five key warning signs of a deep vein blood clot (DVT) often include swelling, pain/tenderness, warmth, redness/discoloration, and sometimes visible veins, usually in one leg or arm, while signs of a pulmonary embolism (PE) like sudden shortness of breath or chest pain are medical emergencies. Recognizing these symptoms early is crucial, as DVT can travel to the lungs, causing a potentially fatal PE.
Cardiac pain is often described as a pressure or squeezing sensation and can radiate to the arm, neck, or jaw. Breast pain is dull, muscle pain is sharp, and heart pain feels like pressure.
Increased Risk of Bleeding: Blood thinners help prevent clots but can also increase the risk of bleeding. If a senior experiences frequent bleeding, such as nosebleeds, easy bruising, or prolonged bleeding from cuts, the doctor may recommend stopping the medication to avoid more serious bleeding complications.
In many cases, you can continue blood thinners on the day of the procedure, but you should consult with the radiologist performing your biopsy as well as your prescribing provider to minimize bleeding/bruising risks while avoiding any complications potentially arising from stopping your blood thinner.
As well as the risk of bleeding, common side effects from anticoagulants include: Headaches. Low blood count (low haemoglobin levels) causing anaemia. You may feel tired, short of breath, pale, experience dizziness or palpitations (noticeable changes to your heartbeats)
Leukemia-related anemia is often accompanied by a low platelet count (thrombocytopenia). Because platelets are essential for proper blood clotting, thrombocytopenia can lead to easy bleeding and bruising.
Symptoms include low mood, depression, anxiety and behavioural changes (irritability, agitation, confusion, aggression, hostility, paranoia, hallucinations and euphoria). Changes in mood vary depending on the individual and the medicine.
Individuals with bleeding disorders, such as hemophilia, or those on anticoagulant medications (blood thinners) are at a higher risk of bruising or internal bleeding from massage. Deep tissue work or strong pressure can cause complications in these cases.
Don't Ignore These 8 Blood Clot Warning Signs
Walking is a low-impact exercise that can help increase blood flow in the legs, reducing the risk of blood clots. Walking for at least 30 minutes a day is recommended to maintain good circulation. Cycling helps keep the leg muscles active, improving blood flow and reducing the risk of blood clots.
How to Check for DVT at Home
Blood-thinning medications carry an increased risk of bleeding. This can be mild, such as small cuts or injuries taking slightly longer than usual to heal. There is also a small chance of more serious bleeding, such as bleeding in or around the brain (haemorrhagic stroke).
A blood clot in the heart or lungs could include symptoms such as chest pain, shortness of breath and upper body discomfort in the arms, back, neck or jaw, suggesting a heart attack or pulmonary embolism (PE).
Blood thinners reduce your risk for heart attack, stroke, and blockages in your arteries and veins by preventing clumps of blood (blood clots) from forming or growing.
The 30-second rule in atrial fibrillation (AFib) is a widely used, though debated, guideline defining an AFib episode as an irregularly irregular heart rhythm lasting at least 30 seconds on an ECG, used to distinguish it from shorter, less significant atrial arrhythmias and help guide diagnosis and treatment, particularly for stroke risk and ablation success. While a standard for trials and device monitoring, newer research suggests shorter runs of AF might still be clinically important, prompting ongoing discussion about whether this threshold accurately reflects stroke risk and overall AF burden.
Pulsed field ablation: A safer, faster AFib treatment
In pulsed field ablation (PFA), ultra-fast electrical pulses destroy the problem cells by creating tiny pores in their membranes. PFA specifically targets heart cells, so it's less likely to damage nearby tissue, reducing the risk of side effects.
Current guidelines support the well-established clinical practice that patients who present with atrial fibrillation (AF) of less than 48 hours duration should be considered for cardioversion, even in the absence of pre-existing anticoagulation.